IBD

AVE-UC (Apheresys and Vedolizumab in Ulcerative Colitis) study.
Combination therapy with leukocytoapheresys and Vedolizumab in patients with ulcerative colitis refractory to anti-TNFsM CappelloPalermo

Efficacy and safety of leukocytapheresis adsorber device LA25: experience with 9 patientsA Ferronato; K I Rodriguez-Castro; E Zanetti; G Errigo; F Sola; G Baldassarre SantorsoVicenza

Combination therapy with leukocytoapheresys and Vedolizumab in a patient with ulcerative colitis refractory to anti-TNFsM Cappello; B Scrivo and A CraxìPalermo